References
- De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP. ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. Ann Intern Med 1994; 120: 834–44.
- Hathorn JW, Lyke K. Empirical treatment of febrile neu-tropenia: evolution of current therapeutic approaches . Clin Infect Dis 1997; 24 (Suppl 2): S256–65.
- ViSCOli C. Planned progressive antimicrobial therapy in neutropenic patients. Br J Haematol 1998; 102: 879–88.
- Winston DJ, Ho WG, Bruckner DA, Champlin RE. Beta-lactam antibiotic therapy in febrile granulocytopenic patients: a randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann Intern Med 1991; 115: 849–59.
- Freifeld AG, Walsh T, Marshall D, et al. Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J Clin Oncol 1995; 13: 165–76.
- The Meropenem Study Group of Leuven, London and Nijmegen. Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. J Antimicrob Chemother 1995; 36: 185–200.
- Cometta A, Glauser M. Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review. J Antimicrob Chemother 1996; 8: 375–81.
- Rubinstein E, Lode H, Grassi C and an Antibiotic Study Group. Ceftazidime monotherapy vs Ceftriaxone/Tobramycin for serious hospital acquired Gram-negative infections. Clin Infect Dis 1995; 20: 1217–28.
- Del Favero A, Menichetti F, Martino P, et al., and the GIMEMA Infection Program. A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neu-tropenia. Clin Infect Dis 2001; 33: 1295–301.
- Cometta A, Zinner S, De Bock R, et al., and the International Antimicrobial Therapy Cooperative Group of the European Organization for Research and treatment of Cancer. Piperacillin-Tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 1995; 39: 445–52.
- Yu LC, Shaneyfelt T, Warner R, Ode D. The efficacy of ticarcillin-clavulanate and gentamicin as empiric treatment for febrile neutropenic pediatric patients with cancer. Pediatr Hematol Oncol 1994; 11: 181–7.
- Micozzi A, Venditti M, Monaco M, et al. Bacteremia due to Stenotrophomonas malthophilia in patients with hematologic malignancies. Clin Infect Dis 2000; 31: 705–11.
- Downhour NP, Peterson EA, Krueger TS, Tongella KV, Nix DE. Severe cellulitis/myosithis caused by Stenophophomonas malthophilia. Ann Pharmacother 2002; 36: 63–6.
- EORTC International Antimicrobial Therapy Project Group. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. J Clin Oncol 1983; 1: 597–603.
- Pizzo PA, Hathorn JW, Hiemenz J, et al. A random-ized trial comparing ceftazidime alone with combination antibi-otic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552–8.
- Fanci R, Paci C, Martinez RL, et al. Management of fever in neutropenic patients with acute leukemia : current role of ceftazidime plus amikacin as empiric therapy. J Chemother 2000; 12: 232–9.